Clinical Trials Directory

Trials / Unknown

UnknownNCT01938534

Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
440 (estimated)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Prospective study : Helicobacter pylori eradication therapy in accordance with past antibiotics use.

Detailed description

Antibiotics resistant is serious problem in helicobacter pylori eradication. Clarithromycin is very important antibiotics in eradication. But clarithromycin resistance is increased. Major cause of clarithromycin resistance is past consumption of macrolide. Thus the investigators propose eradication of macrolide used group bismuth contained four drugs therapy.

Conditions

Interventions

TypeNameDescription
DRUGHelicobacter pylori eradication

Timeline

Start date
2013-09-01
Primary completion
2014-12-01
First posted
2013-09-10
Last updated
2014-01-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01938534. Inclusion in this directory is not an endorsement.